NUVB
Income statement / Annual
Last year (2023), Nuvation Bio Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Nuvation Bio Inc.'s net income was -$75.80 M.
See Nuvation Bio Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$222,000.00 |
$484,000.00 |
$368,000.00 |
$103,000.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$222,000.00 |
-$484,000.00 |
-$368,000.00 |
-$103,000.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$71.29 M
|
$87.82 M
|
$69.04 M
|
$32.60 M
|
$25.11 M
|
$482,667.00
|
| General & Administrative
Expenses |
$26.83 M
|
$31.92 M
|
$24.28 M
|
$10.95 M
|
$6.59 M
|
$509,333.00
|
| Selling & Marketing
Expenses |
$1.70 M
|
$0.00
|
$0.00
|
$0.00
|
$400.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$28.53 M
|
$31.92 M
|
$24.28 M
|
$10.95 M
|
$6.99 M
|
$509,333.00
|
| Other Expenses |
$0.00 |
-$872,000.00 |
-$644,000.00 |
-$271,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$99.82 M |
$119.73 M |
$93.32 M |
$43.55 M |
$32.18 M |
$992,000.00 |
| Cost And Expenses |
$99.82 M |
$119.73 M |
$93.32 M |
$43.55 M |
$32.18 M |
$992,000.00 |
| Interest Income |
$24.61 M |
$7.45 M |
$2.96 M |
$1.95 M |
$1,371.00 |
$0.00 |
| Interest Expense |
$0.00 |
-$9.16 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$222,000.00
|
$484,000.00
|
$368,000.00
|
$103,000.00
|
$12,999.00
|
$992,000.00
|
| EBITDA |
-$99.60 M
|
-$128.69 M
|
-$97.29 M
|
-$43.67 M
|
-$32.09 M
|
$0.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$24.02 M
|
$15.54 M
|
$6.47 M
|
$1.89 M
|
-$1.45 M
|
$0.00
|
| Income Before Tax |
-$75.80 M |
-$104.20 M |
-$86.85 M |
-$41.66 M |
-$33.55 M |
-$992,000.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$15.54 M |
-$7.11 M |
-$2.16 M |
$0.00 |
$0.00 |
| Net Income |
-$75.80 M |
-$88.66 M |
-$79.73 M |
-$39.50 M |
-$33.55 M |
-$992,000.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.35 |
-0.41 |
-0.4 |
-0.4 |
-0.16 |
-0.0122 |
| EPS Diluted |
-0.35 |
-0.41 |
-0.4 |
-0.4 |
-0.16 |
-0.0122 |
| Weighted Average Shares
Out |
$218.88 M
|
$216.72 M
|
$197.89 M
|
$97.53 M
|
$206.67 M
|
$80.99 M
|
| Weighted Average Shares
Out Diluted |
$218.88 M
|
$216.72 M
|
$197.89 M
|
$97.53 M
|
$206.67 M
|
$80.99 M
|
| Link |
|
|
|
|
|
|
